Status:

UNKNOWN

CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)

Lead Sponsor:

Gianluca Pontone, MD, PhD

Collaborating Sponsors:

University of Lausanne Hospitals

Conditions:

Heart Failure

Left Ventricular Systolic Dysfunction

Eligibility:

All Genders

Brief Summary

The DERIVATE study was conceived to integrate the information resulted from clinical data, transthoracic echocardiography, and cardiac magnetic resonance (CMR) imaging to provide a more reliable risk ...

Detailed Description

The current guidelines provide indications for primary prevention implanted cardioverter defibrillator (ICD) therapy based on left ventricle ejection fraction (LVEF) and New York Heart Association (NY...

Eligibility Criteria

Inclusion

  • Heart Failure patients (according to the ACC/AHA classification) with known ischemic cardiomyopathy (ICM) or non ischemic dilated cardiomyopathy (DCM)
  • reduced left ventricle ejection fraction (LVEF) (\<50%)

Exclusion

  • pregnancy
  • current alcohol or drug abuse
  • unstable angina
  • decompensated HF (NYHA class IV) in the previous 1 month
  • acute myocarditis in the previous 3 months
  • recent myocardial infarction (MI) (\<40 days) or)
  • severe valvular disease
  • cardiac amyloidosis
  • hypertrophic cardiomyopathy
  • arrhthmogenic right ventricular cardiomyopathy
  • takotsubo cardiomyopathy
  • congenital heart disease
  • non CMR compatible device
  • estimated glomerular filtration rate ≤30 mL/min/1.73m2
  • other contraindication to gadolinium contrast agent
  • severe claustrophobia
  • participating in other trials with an active treatment arm (not to exclude patients who are in trials of diagnostic techniques or approved therapies)
  • unwilling or unable to provide informed consent.

Key Trial Info

Start Date :

January 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2020

Estimated Enrollment :

4000 Patients enrolled

Trial Details

Trial ID

NCT03352648

Start Date

January 1 2007

End Date

December 1 2020

Last Update

June 6 2019

Active Locations (29)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (29 locations)

1

Loyola University of Chicago,

Chicago, Illinois, United States, 60611

2

Medical University of South Carolina

Charleston, South Carolina, United States, 29402

3

KU Leuven-University of Leuven

Leuven, Belgium, 3000

4

St.Luke's Hospital Thessaloniki

Thessaloniki, Greece, 57010